Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients

NCT05433350 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Trypanosomiasis, African
Trypanosoma Brucei Gambiense; Infection
Sleeping Sickness

Interventions

DRUG: Acoziborole

Sponsor

Drugs for Neglected Diseases